Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Shoei Yakuhin Co., Ltd. (3537:JPX), powered by AI.
Shoei Yakuhin Co., Ltd. is currently trading at ¥1,599. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Shoei Yakuhin Co., Ltd. on Alpha Lenz.
Shoei Yakuhin Co., Ltd.'s P/E ratio is 10.3.
“Shoei Yakuhin Co., Ltd. trades at a P/E of 10.3 (undervalued) with modest ROE of 6.2%.”
Ask for details →Shoei Yakuhin Co., Ltd. is a distinguished entity in the pharmaceutical and chemical industry, primarily focused on manufacturing and distributing a diverse range of products. Its primary function is to develop and supply active pharmaceutical ingredients, excipients, and other chemical materials pivotal for medication and healthcare product formulation. The company plays a crucial role in the healthcare sector by ensuring a consistent supply of high-quality pharmaceutical substances that contribute to the effectiveness and safety of various medical treatments. Notably, Shoei Yakuhin Co., Ltd. also extends its reach into the chemicals industry, supplying materials for industrial applications. This dual focus not only underscores its impact on health-related industries but also highlights its versatility in adapting to market needs. With a commitment to quality and innovation, Shoei Yakuhin Co., Ltd. remains a significant player in the pharmaceutical supply chain, influencing the broader landscape of healthcare and industrial chemical solutions.
“Shoei Yakuhin Co., Ltd. trades at a P/E of 10.3 (undervalued) with modest ROE of 6.2%.”
Ask for details →Shoei Yakuhin Co., Ltd. (ticker: 3537) is a company listed on JPX in the Basic Materials sector (Specialty Chemicals). It has approximately 77 employees. Market cap is $5.4B.
The current price is 1,599 with a P/E ratio of 10.33x and P/B of 0.61x.
ROE is 6.18% and operating margin is 2.24%. Annual revenue is $25.0B.